Evidence map›Paper›PMID 36044723›Full record

ArticleAnnals of the American Thoracic Society2023

Systemic Corticosteroids in the Management of Pediatric Cystic Fibrosis Pulmonary Exacerbations.

Chelsea S Davis, Anna V Faino, Frankline Onchiri, Ronald L Gibson, Lina Merjaneh, Bonnie W Ramsey, Margaret Rosenfeld, Jonathan D Cogen

Open access · greenAbstract read
In one paragraph

Article in Annals of the American Thoracic Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Cystic fibrosis year in review 2023.Pediatric pulmonology · 2024
    Review
  6. STOP Using Corticosteroids in Cystic Fibrosis Pulmonary Exacerbations.Annals of the American Thoracic Society · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chelsea S DavisDivision of Pulmonary and Sleep Medicine and.
Anna V FainoCore for Biostatistics, Epidemiology, and Analytics in Research, Seattle Children's Research Institute, Seattle, Washington.
Frankline OnchiriCore for Biostatistics, Epidemiology, and Analytics in Research, Seattle Children's Research Institute, Seattle, Washington.
Ronald L GibsonDivision of Pulmonary and Sleep Medicine and.
Lina MerjanehDivision of Endocrinology and Diabetes, Department of Pediatrics, University of Washington, Seattle, Washington; and.
Bonnie W RamseyDivision of Pulmonary and Sleep Medicine and.
Margaret RosenfeldDivision of Pulmonary and Sleep Medicine and.
Jonathan D CogenDivision of Pulmonary and Sleep Medicine and.
Pulmonary Associates · USUniversity of Washington · US

Funding

Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss, Lucas R Hoffman · 2010 to 2026
$21.4M
NIDDK NIH HHS P30 DK089507
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cystic FibrosisAdrenal Cortex HormonesAnti-Bacterial AgentsChildDisease ProgressionForced Expiratory VolumeHumansProspective StudiesRetrospective StudiesAdrenal Cortex HormonesAnti-Bacterial Agentscystic fibrosispediatricspulmonary exacerbationsystemic corticosteroids

Identifiers

PMID36044723
PMCPMC12039857
OpenAlexW4293812705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.